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Objectives: Pregnancy represents a metabolic
challenge to women; in a normal pregnancy, transient
metabolic changes occur that support the needs of the
growing fetus. It is possible that repeating this
challenge within a relatively short amount of time may
result in lasting damage to the woman’s cardiovascular
health. Conversely, it is also possible that a long
interpregnancy interval (IPI) may reflect subfertility,
which has been found to be associated with
cardiovascular disease (CVD). We examine the
associations of short and long IPI with measures of
cardiovascular health.
Design: Prospective cohort.
Setting: Mothers of the Avon Longitudinal Study of
Parents and Children (ALSPAC).
Participants: Women with two live births in order to
control for confounding by parity.
Outcome measures: Arterial distensibility, common
carotid intima, adiposity, blood pressure, lipids,
glucose, insulin, proinsulin, triglycerides, C reactive
protein.
Results: 25% (n=3451) of ALSPAC mothers had
provided sufficient data to determine full reproductive
history—of these, 1477 had two live births, with 54%
mothers having non-missing data on all variables
required for our analyses. A total of 1268 mothers with
IPI (interbirth interval minus 9 months’ gestation) had
CVD risk factors measured/imputed at mean age
48 years. After adjusting for confounding, we found no
association of either short (≤15 months) or long
(>27 months) IPI and increased levels of
cardiovascular risk factors. There was some suggestion
that women with long and short IPIs had a more
favourable lipid profile compared with women whose
IPI was 16–27 months; however, the differences were
small in magnitude and imprecisely estimated.
Conclusions: This study does not support the
hypothesis that either long or short IPI is a risk factor
for later cardiovascular health.
INTRODUCTION
Pregnancy represents a metabolic challenge
to women; in a normal pregnancy, transient
metabolic changes occur that support the
needs of the growing fetus. Women become
relatively insulin resistant, hyperlipidaemic
and experience upregulation of coagulation
factors and the inﬂammatory cascade.1 A
recent systematic review and meta-analysis
found that a short interpregnancy interval
(IPI; <12 months) was associated with an
increased risk of stillbirths, early neonatal
death, preterm birth and low birth weight.2
Associations between IPI and cardiovascular
outcomes, however, are not known. Given
Strengths and limitations of this study
▪ Its prospective design with detailed data on
reproductive history.
▪ The availability of a wide range of objectively
measured cardiovascular disease risk factors and
the large sample size.
▪ First study to examine the association of inter-
pregnancy interval (IPI) with cardiovascular risk
factors.
▪ As with other prospective cohort studies, there
was loss to follow-up, with those attending and
completing all questionnaires tending to come
from a higher socioeconomic background.
▪ Our analysis was restricted to women who had
two live births to remove confounding by parity,
which means that our findings may not general-
ise to women who had three or more children.
We did not find any evidence of any strong dif-
ferences between women who had either only
one birth or three or more births and women
with two live births/stillbirths.
▪ IPI was calculated by subtracting the average
gestation period from the birth interval. We do
not believe that this would have biased our find-
ings as we used IPI as a categorical variable,
and therefore any fluctuations around the
average 9-month gestation would not have
altered the findings substantially.
▪ Only generalisable to a largely white European
population.
▪ The population being studied is still young
(mean age at clinic=48), and therefore it is pos-
sible that the association may emerge at older
ages, when interindividual variability in cardio-
vascular risk factors becomes greater.
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the cardiovascular changes during pregnancy, it is
possible that if this challenge is repeated within a rela-
tively short amount of time, the effects on a woman’s
metabolic system may be exacerbated and/or be longer
lasting. This may have a deleterious effect on her long-
term cardiovascular health.
Conversely, it is also possible that a long IPI is
associated with increased cardiovascular risk. Longer
IPIs may reﬂect subfertility, which has been found to be
associated with cardiovascular disease (CVD).3 4
Here we examine the associations of short and long IPI
with measures of cardiovascular health (arterial distensibil-
ity, common carotid intima, adiposity, blood pressure,
lipids, glucose, insulin, proinsulin, triglycerides, C reactive
protein (CRP)) assessed at a mean age of 48 years.
METHODS
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective population-based birth cohort
that recruited 14 541 pregnant women resident in Avon,
UK, who had expected delivery dates between 1 April
1991 and 31 December 1992. ALSPAC has previously
been described in detail,5 and the study website contains
details of all the available data through a fully searchable
data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary).
Pregnancy data and IPI
In order to remove confounding by parity, which is
known to be associated with CVD,6–12 we restrict our
analyses to women with two pregnancies resulting in live
births (self-reported).Women were eligible for inclusion
in this study if they had two pregnancies that resulted in
live births and completed all the questionnaires neces-
sary to ascertain full reproductive history. The study ﬂow
diagram is presented in ﬁgure 1.
On recruitment into the cohort (approximately
18 weeks’ gestation), women were asked to complete a
questionnaire about their health prior to the current preg-
nancy, including the number of previous pregnancies; the
number of miscarriages/abortions; the outcome (live
birth, stillbirth, miscarriage, abortion or termination, live
born baby that died, live born baby still alive and other)
and end date (ie, delivery or other outcome) of their most
recent previous pregnancy. We used these data, along with
subsequent questionnaires (n=5) throughout the 18-year
period, leading to our outcome assessment to identify
women who had two pregnancies that resulted in a live
birth. We only included pregnancies that resulted in a live
birth and the two pregnancies that we used for the interval
could have included those occurring before or after the
pregnancy at which women were recruited.
Assessment of cardiovascular risk factors
Between 2009 and 2011, ALSPAC mothers (N=11, 264
women) were invited to a research clinic assessment at
which a range of cardiovascular outcomes were assessed;
this clinic took place between 1.6 and 20.3 years
(median 18) since the second birth deﬁning the end of
the IPI. Not all of these women were eligible for inclu-
sion in our analysis as not all of them had full reproduct-
ive histories recorded.
Carotid intima media thickness (cIMT) for the left
and right common carotid artery scans were obtained
via high-resolution B ultrasound and imaged longitudin-
ally 1 cm proximal to the carotid bifurcation following a
standardised protocol using a ZONARE z.one Ultra con-
vertible ultrasound system with an L10-5 linear trans-
ducer. Images were focused on the posterior (far) wall
of the artery and the zoom function was used to magnify
the area. Ten-s cine loops were recorded in DICOM
format and analysed ofﬂine using Carotid Analyser for
Research (Vascular Research Tools 5, Medical Imaging
Applications, LLC 2008). Three consecutive cardiac
cycles were identiﬁed and three measures of cIMT were
taken from end-diastolic frames and averaged. This was
carried out for right and left carotid arteries. Arterial
distensibility was calculated as the difference between
systolic and diastolic arterial diameter. The mean of the
left-sided and right-sided readings was used in analyses.
The images were analysed by a single trained reader.
Blood pressure was measured while the women were
lying down with the use of an Omron M6 monitor
(Omron Healthcare UK Ltd, Milton Keynes, UK). Two
readings of systolic and diastolic blood pressure were
recorded on each arm, and the mean of these four read-
ings was used here. Heart rate was measured in the
sitting and standing positions.
Blood samples were taken after an overnight fast for
those attending in the morning or after a minimum 6 h
fast for those attending the clinic after 14:00. Blood
samples were obtained, centrifuged, separated and
frozen at −80°C within 30 min. Plasma glucose was mea-
sured by the automated enzymatic (hexokinase)
method. Plasma insulin was measured by ELISA
(Mercodia, Uppsala, Sweden) that does not cross react
with proinsulin or c-peptide, and proinsulin was also
measured by ELISA (Mercodia) that is a solid-phase
2-site enzyme immunoassay for the quantiﬁcation of
human proinsulin. Lipids were measured by automated
analyser with enzymatic methods. CRP was measured by
automated particle-enhanced immunoturbidimetric
assay (Roche UK, Welwyn Garden City, UK).
Whole body fat mass was measured using dual-energy
X-ray absorptiometry whole body scans. Weight and
height were measured with the participants in light
clothing and without shoes. Weight was measured to the
nearest 0.1 kg with the use of Tanita scales. Height was
measured to the nearest 0.1 cm with a Harpenden stadi-
ometer. Waist circumference was measured twice to the
nearest 1 mm at the midpoint between the lower ribs
and the pelvic bone with a ﬂexible tape. The mean of
the two measures is used here.
A total of 4834 women attended the clinic (43%
response).5 Women attending the clinic had a mean age
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of 48 years. Women pregnant at the time of clinic assess-
ment were excluded from our analyses (n=7). Only 954
women attending the clinic and not pregnant at the
time of clinic assessment had full reproductive histories.
Measurement of confounding factors
Information on pre-pregnancy weight and height, smoking
in pregnancy, single parent households, ethnicity, education
and social class were obtained from questionnaires com-
pleted at the time of recruitment during the index preg-
nancy. Ethnicity was categorised as white or non-white.
Education was categorised as below or above university edu-
cation. Household occupational social class was deﬁned
according to the 1991 British Ofﬁce of Population and
Census Statistics classiﬁcation (classes I (professional/man-
agerial) to V (unskilled manual workers)) using either the
woman’s occupation or that of her partners, whichever was
highest. Smoking in pregnancy was categorised as ever or
never smoked during pregnancy, at approximately 18–
20 weeks’ gestation. Ideally, we would wish to measure these
potential confounders in relation to the ﬁrst pregnancy of
the interval and for some to have time updated (ie, also
information from the second pregnancy) measurements. In
this study, however, we only have data on the pregnancy
when women were recruited, and this is the ﬁrst pregnancy
of the interval for 30.9% of the women and the second for
the remaining 69%. Participant’s age at clinic attendance was
included as a confounding factor.
Statistical analysis
Distributions of insulin, proinsulin, triglyceride, CRP,
glucose and low-density lipoprotein were right skewed,
and so were log transformed for all regression model
analyses, which ensured that the residuals were approxi-
mately normally distributed. We compared women with
sufﬁcient data for us to detail their full reproductive
history with those women with insufﬁcient data, in terms
of all confounding variables. Similarly, we compared
those women who formed our eligible sample (only two
live births and not pregnant at the time of outcome
assessment) with women with either only 1 birth or ≥3
births, in terms of all confounding and outcome vari-
ables. χ2 Tests for categorical data and t tests for continu-
ous normally distributed variables were performed. IPI
was calculated as the difference between the dates of
delivery of the two pregnancies, minus the average gesta-
tion period (9 months). IPI was grouped into three cat-
egories: ≤15, 16–27 and >27 months; these groups
correspond to ≤2, 2–3 and >3 years between births.
The association between our categorised measure of
IPI and each outcome was assessed using multiple linear
regression, with and without adjustment for potential
confounders, comparing both short and long IPI with
the reference category of 16–27 months. All analysis was
conducted in Stata/MP V.12.0.
In order to assess whether our results were biased as a
result of some confounders being measured at the ﬁrst
pregnancy of the IPI for some women and the second
for others, we stratiﬁed our results by whether the
ALSPAC child was the ﬁrst or second pregnancy of the
interval.
Dealing with missing data
Within our eligible study sample of 1268, there were some
missing data on potential confounders and outcome mea-
surements (data on exposure had to be observed to be
Figure 1 Flow chart of selection
of women for analysis. *All 5
questionnaires were not
completed.
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eligible). The extent of missing data varied from 0% to
29%, with blood-based measures having the most missing
data (see online supplementary table S1). In order to
increase efﬁciency and minimise selection bias, we
imputed missing variables for eligible participants who
had missing data on outcomes or confounders, using
multivariate multiple imputation. We included all the
exposure, confounder and outcome measures in the
imputation equations. We used switching regression in
Stata and carried out 20 cycles of regression switching and
generated 20 imputation datasets. The main analysis
results are obtained by averaging across the results from
each of these 20 datasets using Rubin’s rules and the SEs
for any regression coefﬁcients (used to calculate p values
and 95% CIs) to take account of uncertainty in the impu-
tations as well as uncertainty in the estimate.13 We carried
out all our linear regression analyses using the imputed
and complete-case datasets. Online supplementary table
S1 shows that the distributions of variables in the imputed
and non-imputed/complete-case datasets were similar.
RESULTS
Sample description
A total of 3451 women of 13 713 recruited women who had
a live birth had sufﬁcient data to describe a full reproductive
history; of these, 1970 were excluded because they had
either just 1 (n=971) or ≥3 births (n=999). A further four
were pregnant at the time of assessment and were excluded.
Of the remaining 1477 women who had two live births, 147
were excluded as they were recruited into the cohort
during their second pregnancy, with the most recent previ-
ous pregnancy resulting in a miscarriage, termination,
stillbirth or ‘other’ outcome. IPI could be calculated for
1268 of the remaining eligible women (95%). Of these
women, 954 attended the clinic assessment in 2009–2011
and 792 women had complete data for all outcome and
confounder measures (ﬁgure 1). Thus, our complete case
analysis was performed on 792 women, and analysis using
multivariate multiple imputation included 1268 women.
Women included in the complete case analysis versus
women with missing data on covariates and/or outcome
variables had similar IPI (see online supplementary
table S2).
Women who had provided sufﬁcient data to describe
their full reproductive history were on average slightly older,
from a higher socioeconomic background, more likely to
be smokers and white, and less likely to be in a single
parent household, compared with women with insufﬁcient
data to describe their full reproductive history (table 1).
Women eligible for this study (two live births) were more
likely to be smokers compared to women with either 1 or
≥3 births (see online supplementary table S3). No clear dif-
ferences with regard to the other confounding variables
were observed. There were small differences observed in
terms of cardiovascular risk factors (see online supplemen-
tary table S3), with women with single and three or more
pregnancies having slightly worse cardiovascular risk proﬁle
compared to women with two pregnancies.
Participant characteristics
The characteristics of women according to their IPI are
presented in table 2. There were no noticeable differences
between IPI categories in terms of pre-pregnancy body
mass index (BMI), ethnicity, social class, education and
Table 1 Characteristics of women with full reproductive histories compared to those with incomplete reproductive histories




complete data n=3451 p Value
Categorical variables—n (%)
Ethnicity n=8653 n=3417
White 8381 (96.9) 3370 (98.6) <0.001
Social class n=7927 n=3335
I 842 (10.6) 664 (19.9) <0.001
II 3099 (39.1) 1601 (48.0)
III (non-manual) 2135 (26.9) 738 (22.1)
III (manual) 1261 (15.9) 258 (7.7)
IV and V 590 (7.4) 74 (2.2)
Education n=8739 n=3425
University level or above 826 (9.5) 742 (21.7) <0.001
Single parent household n=9136 n=3403
Yes 616 (6.7) 102 (3.0) <0.001
Ever smoked n=9365 n=3441
Yes 5124 (54.7) 1369 (39.8) <0.001
Continuous variables—mean (SD*)
Age at birth of the ALSPAC
index child
n=10258 n=3451
<0.00127.4 (5.0) 29.8 (4.4)
*T test for normally distributed data.
ALSPAC, Avon Longitudinal Study of Parents and Children.
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smoking status. Women with a longer IPI, however, were
more likely to be in single parent households and slightly
younger compared with all other women (table 2). Table 3
presents the distribution of the outcome variables for all
those women who attended the follow-up assessment in
2009–2011 and who had an IPI calculated for this analysis.
Association between IPI and CVD risk factors
Crude associations of IPI with outcomes are presented
in tables 4 and 5. We found no evidence that women
with either short or long IPI had more adverse cardio-
vascular risk factors compared with women with an IPI
between 16 and 27 months. There was some suggestion
Table 2 Characteristics of women by interpregnancy interval N=1268
Interpregnancy interval of all included women n=1268
≤15 months 16–27 months >27 months
p Valuen=269 n=412 n=582
Continuous variables—mean (SD)
Age at birth of the ALSPAC index child n=269 n=412 n=582
<0.00130.4 (3.7) 30.2 (3.6) 29.3 (4.3)
Pre-pregnancy BMI (kg/m2)* n=256 n=391 n=534
0.622.6 (2.9) 22.5 (3.4) 22.7 (3.4)
Categorical variables—n (%)
Ethnicity n=267 n=411 n=577
0.4White 265 (99.3) 406 (98.8) 566 (98.1)
Social class n=261 n=409 n=568
I (highest; professional) 59 (22.6) 89 (21.8) 109 (19.2)
0.2
II 127 (48.7) 198 (48.4) 274 (48.2)
III (non-manual) 54 (20.7) 74 (18.1) 141 (24.8)
III (manual) 17 (6.5) 37 (9.1) 34 (6.0)
IV and V (lowest; unskilled manual) 4 (1.5) 11 (2.7) 10 (1.8)
Education n=269 n=411 n=580
0.4University level or above 66 (24.5) 82 (20.0) 124 (21.4)
Single parent household n=269 n=412 n=578
<0.001Yes 1 (0.4) 3 (0.7) 24 (4.2)
Smoked during pregnancy* n=268 n=412 n=581
1.0Yes 101 (38.0) 152 (37.0) 2013 (36.7)
*Relates to the first child in some women and second in others.
ALSPAC, Avon Longitudinal Study of Parents and Children; BMI, body mass index.
Table 3 Distribution of pre-pregnancy BMI and outcomes at research clinic assessment (2009–2011) with IPI
IPI n=1268
≤15 months 16–27 months >27 months
n= n=271 n= n=415 n= n=582
Mean (SD)
Pre-pregnancy BMI (kg/m2) 260 22.6 (2.8) 399 22.5 (3.4) 553 22.7 (3.4)
BMI (kg/m2) 203 25.9 (4.5) 313 25.8 (4.7) 433 26.1 (4.8)
Waist (cm) 203 82.6 (11.4) 313 82.6 (11.2) 433 83.3 (11.2)
SBP (mm Hg) 202 118.1 (12.5) 304 118 (12.3) 424 117.4 (12.5)
DBP (mm Hg) 202 71.7 (8.3) 304 71.7 (8.5) 424 71.4 (8.1)
Heart rate 202 84.3 (11.1) 304 83.7 (10.7) 424 83.6 (11)
Fat mass (kg) 204 26 (10.1) 314 25.9 (9.9) 428 26.3 (10.1)
Average arterial distensibility (mm) 204 0.5 (0.1) 315 0.5 (0.1) 430 0.5 (0.1)
Common carotid intima (mm) 204 0.6 (0.1) 315 0.6 (0.1) 430 0.6 (0.1)
Cholesterol (mmol/L) 194 4.9 (0.8) 303 5 (0.9) 410 4.9 (0.9)
HDL (mmol/L) 194 1.5 (0.4) 303 1.5 (0.4) 410 1.5 (0.4)
Non-HDL cholesterol (mmol/L) 194 3.4 (0.9) 303 3.5 (0.9) 410 3.4 (0.9)
Median (IQR)
Insulin (µ/L) 193 4.3 (3.2 to 6.4) 301 4.3 (3 to 6.3) 408 4.6 (3.3 to 6.8)
Proinsulin (pu/L) 194 5 (3.6 to 7.3) 302 4.9 (3.5 to 6.6) 409 5.1 (3.6 to 7.9)
Triglyceride (mmol/L) 194 0.8 (0.6 to 1.1) 303 0.9 (0.7 to 1.2) 410 0.9 (0.7 to 1.1)
C reactive protein (mg/L) 194 0.9 (0.4 to 1.9) 303 0.9 (0.5 to 2) 410 1 (0.5 to 2.5)
Glucose (mmol/L) 194 5.2 (4.9 to 5.4) 303 5.2 (4.9 to 5.4) 410 5.1 (4.9 to 5.4)
BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; IPI, interpregnancy interval; SBP, systolic blood pressure.
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that women with long and short IPIs had a more favour-
able lipid proﬁle compared with women whose IPI was
16–27 months; however, the differences were small in
magnitude and imprecisely estimated, with the 95% CI
including the null value.
Adjustment for potential confounders or for potential
mediation by BMI at outcome assessment did not
change results (tables 4 and 5 and online supplementary
table S4). These ﬁndings are similar to the results when
the analysis was restricted to complete cases (see online
supplementary tables S5 and S6). The results were also
similar when the women were stratiﬁed according to
whether the ALSPAC child was the ﬁrst or second preg-
nancy (results not shown—available from authors on
request).
DISCUSSION
We found no association between short or long IPI and
levels of cardiovascular risk factors in a cohort of women
with a mean age of 48 years. This is in contrast to our
initial hypotheses that shorter IPIs may give a woman’s
cardiovascular system insufﬁcient time to recover, that
longer IPIs may reﬂect subfertility and that both may be
associated with adverse levels of cardiovascular risk
factors. We actually found weak evidence that women
with short (≤15 months) and long IPIs (>27) had a
more favourable lipid proﬁle (ie, the opposite of our
initial hypotheses) compared with women with an IPI
between 16 and 27 months, but the associations were
not large, were imprecisely estimated, and were not con-
sistent across all outcomes and may be due to chance.
To the best of our knowledge, this is the ﬁrst study to
examine the relationship between pregnancy interval
and subsequent cardiovascular outcomes. Several previ-
ous studies have examined the association of parity with
cardiovascular outcomes, with most,6–12 though not
all,14–16 ﬁnding that greater parity is related to more
adverse risk factors and greater disease risk. A recent
study investigated this association in a population of 1.3
million, using the Swedish registry data,12 and found a
J-shaped relationship between parity and CVD risk, with
nulliparous and grand multiparous (≥5 births) having
elevated risk compared to those women with two births.
One possible mechanism for this association is that mul-
tiparous women are more likely to have births closer
together, and the repetition of the cardiovascular chal-
lenge within a relatively short amount of time may lead
to the effects on a women’s metabolic system being exa-
cerbated and/or longer lasting. Our ﬁndings do not
support this hypothesis. Our results therefore suggest
that the association of parity with greater CVD risk may
be through another mechanism. Possible theories for
the mechanisms underlying the greater risk of CVD
after two children are: (1) other adverse lifestyle factors
being adopted as a family size increases; (2) sociodemo-
graphic and other characteristics associated with
increased risk of CVD also being associated with having
more children and (3) adverse metabolic disturbances
accumulating over pregnancies.12
Table 4 Unadjusted and confounder-adjusted analysis of the association between interpregnancy interval and blood-based




≤15 months 16–27 months >27 months
β* (95% CI) p Value Ref group β* (95% CI) p Value
Cholesterol (mmol/L) Model 1† −0.1 (−0.2 to 0.1) 0.3 0 −0.1 (−0.2 to 0.03) 0.1
Model 2‡ −0.1 (−0.3 to 0.1) 0.2 0 −0.05 (−0.2 to 0.1) 0.4
HDL (mmol/L) Model 1† 0.03 (−0.04 to 0.1) 0.4 0 −0.01 (−0.1 to 0.05) 0.8
Model 2‡ 0.03 (−0.04 to 0.1) 0.4 0 0.01 (0 to 0.1) 0.6
Per cent change
(95% CI) p Value Ref group
Per cent change
(95% CI) p Value
Insulin (µ/L)§ Model 1† 1 (0.9 to 1.1) 0.8 0 1.1 (1 to 1.2) 0.1
Model 2‡ 1 (0.9 to 1.1) 0.9 0 1 (1 to 1.1) 0.4
Proinsulin (pmol/L)§ Model 1† 1 (0.9 to 1.1) 0.7 0 1.1 (1 to 1.1) 0.1
Model 2‡ 1 (0.9 to 1.1) 0.8 0 1 (1 to 1.1) 0.2
Triglyceride
(mmol/L)§
Model 1† 0.9 (0.9 to 1) 0.1 0 0.9 (0.9 to 1) 0.03
Model 2‡ 0.9 (0.9 to 1) 0.1 0 0.9 (0.9 to 1) 0.02
CRP (mg/L)§ Model 1† 0.9 (0.8 to 1.1) 0.4 0 1.1 (0.9 to 1.2) 0.4
Model 2‡ 0.9 (0.8 to 1.1) 0.5 0 1 (0.9 to 1.2) 0.6
Glucose (mmol/L) § Model 1† 1 (1 to 1) 0.7 0 1 (1 to 1) 0.4
Model 2‡ 1 (1 to 1) 0.6 0 1 (1 to 1) 0.3
*Mean difference compared with 16–27 months.
†Unadjusted model.
‡Adjusted for maternal age, maternal ethnicity, social class, education, pre-pregnancy BMI, ever smoking during pregnancy.
§Log transformed.
BMI, body mass index; CRP, C reactive protein; HDL, high-density lipoprotein.
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The strengths of this study include the prospective
design; detailed data on reproductive history; the avail-
ability of a wide range of objectively measured CVD risk
factors; and the large sample size. We were able to adjust
for a range of potential confounding factors, and we
restricted our analyses to women who had two live births
in order to remove confounding by parity. To the best of
our knowledge, this is the ﬁrst study to examine the asso-
ciation of IPI with cardiovascular risk factors. The ﬁnd-
ings of this study, however, should be considered in light
of several limitations. As with other prospective cohort
studies, there was loss to follow-up, with those attending
and completing all questionnaires tending to come from
a higher socioeconomic background. This means that
the women included in our analysis are not a representa-
tive sample of the full ALSPAC cohort; some studies
suggest that lack of generalisability does not necessarily
result in selection bias,17–20 but we cannot be certain of
this from the current analysis, and replication of our
results in other studies with different distributions of
sociodemographic variables would be beneﬁcial. Missing
data would bias our results if the association between IPI
and cardiovascular risk factors differed in those included
in our analyses and those excluded due to missing data.
We are unable to test this assumption, but have no
reason to suspect that it may be violated. One important
consideration when interpreting our results is that we
have restricted our analyses to women who had two live
births. While we feel that this was a sensible analysis
strategy in order to remove confounding by parity, it
means that our ﬁndings may not generalise to women
who had three or more children. We did not ﬁnd any
evidence of any strong differences between women who
had either only one birth or three or more births and
women with two live/stillbirths (see online supplemen-
tary table S3). IPI was calculated by subtracting the
average gestation period (9 months) from the birth
interval; ideally, we would have liked to have calculated
exact gestation periods for each live birth. We do not,
however, believe that this would have biased our ﬁndings
as we used IPI as a categorical variable, and therefore
any ﬂuctuations around the average 9 month gestation
would not have altered the ﬁndings substantially. It is
possible that by calculating our IPI in this way we have
attenuated our results towards the null. A further limita-
tion of this study is these ﬁndings are only generalisable
to a largely white European population with a higher
socioeconomic status. As the population being studied is
still young (mean age at clinic=48), it is possible that the
association may emerge at older ages, when interindivi-
dual variability in cardiovascular risk factors becomes
greater. Ideally, we would have measured pre-pregnancy
BMI and smoking during pregnancy for the ﬁrst preg-
nancy of all women. Owing to our study design, this was
not possible. These measurements are from the ﬁrst
pregnancy in some women and the second pregnancy in
others. There is therefore the possibility that these mea-
surements are not a reasonable representation of levels
Table 5 Unadjusted and confounder adjusted analysis of the association between interpregnancy interval and








β* (95% CI) p Value
Ref
group β* (95% CI) p Value
Average arterial distensibility (mm) Model 1† −0.0003 (−0.02 to 0.02) 1 0 0.02 (0.001 to 0.04) 0.04
Model 2‡ 0.002 (−0.02 to 0.02) 0.9 0 0.01 (−0.003 to 0.03) 0.1
Common carotid intima (mm) Model 1† 0.005 (−0.01 to 0.02) 0.4 0 −0.0008 (−0.01 to 0.01) 0.9
Model 2‡ 0.003 (−0.01 to 0.01) 0.6 0 0.002 (−0.01 to 0.01) 0.7
Total body fat mass (kg)§ Model 1† −0.2 (−1.7 to 1.3) 0.8 0 0.4 (−0.8 to 1.7) 0.5
Model 2‡ −0.3 (−1.6 to 0.9) 0.6 0 −0.05 (−1.1 to 1) 0.9
BMI (kg/m2) Model 1† 0.03 (−0.7 to 0.8) 0.9 0 0.3 (−0.3 to 0.9) 0.3
Model 2‡ −0.02 (−0.6 to 0.5) 0.9 0 0 (−0.4 to 0.5) 0.8
Waist (cm) Model 1† −0.1 (−1.8 to 1.6) 0.9 0 0.6 (−0.8 to 2.1) 0.4
Model 2‡ −0.3 (−1.7 to 1.1) 0.7 0 0.1 (−1.1 to 1.4) 0.8
Systolic BP (mm Hg) Model 1† 0.1 (−1.9 to 2.2) 0.9 0 −0.6 (−2.3 to 1.2) 0.5
Model 2‡ 0.1 (−1.9 to 2.1) 0.9 0 −0.5 (−2.3 to 1.2) 0.5
Diastolic BP (mm Hg) Model 1† 0.1 (−1.3 to 1.4) 0.9 0 −0.4 (−1.6 to 0.8) 0.5
Model 2‡ 0.1 (−1.2 to 1.5) 0.9 0 −0.5 (−1.7 to 0.7) 0.4
Heart rate Model 1† 0.4 (−1.6 to 2.4) 0.7 0 0 (−1.7 to 1.6) 1
Model 2‡ 0.3 (−1.7 to 2.4) 0.7 0 0 (−1.6 to 1.7) 1
*Mean difference compared with 16–27 months.
†Unadjusted model.
‡Adjusted for age, ethnicity, social class, education, pre-pregnancy BMI, ever smoking during pregnancy.
§Height and height2 were included into the model.
BP, blood pressure; BMI, body mass index.
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in the ﬁrst pregnancy for all women; this may lead to
residual confounding. However, given that the associa-
tions we observe are null, we do not think this has
biased our results.
In conclusion, our results do not support an association
between IPI and cardiovascular risk factors, though our
ﬁndings must be interpreted in light of the large losses to
follow-up and limitations in our measurement of IPI.
Further studies in other populations with more detailed
data on gestational age at delivery of all pregnancies, in
different settings such as low-income countries where the
social patterning of IPI may differ and in older women
with greater interindividual variability in cardiovascular
risk factors would provide a more comprehensive under-
standing of these associations.
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